Search results
To Your Good Health: Over-the-counter eye drops safe to use with AMD medication
The Marshall News Messenger· 4 days agoROACH: I am a healthy 67-year-old female being treated with Eylea for wet age-related macular ...
Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 3 days agoOcugen (OCGN) is expected to provide updates regarding the developmental program of its lead...
At 6.48% CAGR, Vitrectomy Devices Market to Reach USD 2.05 Billion By 2031 Driven by Increasing...
Digital Journal· 3 days agoThe global Vitrectomy Devices Market is set to witness a significant surge in valuation, projected...
Sigma Planning Corp Reduces Stake in REGENXBIO Inc. (NASDAQ:RGNX)
ETF DAILY NEWS· 12 hours agoSigma Planning Corp lowered its position in REGENXBIO Inc. (NASDAQ:RGNX – Free Report) by 63.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Saffron and sight: Study explores longer-term effects
Nutraingredients.com· 6 days agoAccording to a recent study published in BMJ Open Ophthalmology, 12 months of saffron...
Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment...
Morningstar· 4 days agoDALLAS, April 25, 2024 /PRNewswire/ -- Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced today the appointment of Allen C. Ho, MD, FACS, FASRS, as Chief Medical
JD Supra: Regeneron v Novartis and Vetter: Walker Process Client Update
JD Supra· 4 days agoIn an appeal that attracted a dozen amici, including the Department of Justice, the Federal Trade Commission, five states, and the District of Columbia, the Second Circuit gave the Walker Process ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 1 day agoSightMD Pennsylvania Expands Practice with Acquisition of James Lewis, MD PR Newswire HAUPPAUGE, N.Y., April 28, 2024 SightMD Pennsylvania, a leading multi-specialty ophthalmology platform, is pleased to announce the acquisition of James Lewis,
FDA Roundup: April 26, 2024
FOX21 Colorado Springs· 3 days agoThis represents the first FDA approval of a systemic therapy for the treatment of patients with pediatric LGG with BRAF rearrangements, including fusions. Full prescribing ...
Belite Bio secures $25 million in registered direct offering By Investing.com
Investing.com· 4 days agoBelite Bio, Inc (NASDAQ: BLTE), a biopharmaceutical company specializing in degenerative retinal...
